Research Consortium, Testing Service Hope to Turn Cancer Genome Analyses into Rx Selections | GenomeWeb

A public-private research consortium that includes Harvard Medical School and the Max Planck Institute for Molecular Genetics in Berlin plans to sequence the genomes and transcriptomes of 1,000 cancer patients, and to make treatment recommendations based on the results.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.